The Milken Institute Future of Health Summit – “Is AI Just What the Doctor-or Patient-Ordered?” Panel Discussion
The Milken Institute Future of Health Summit (FHS) convened the best minds in the world to confront the most significant health challenges by matching human, financial, and scientific resources with the most innovative, inclusive, and impactful ideas. Watch now the Future of Health Summit and the panel titled “Is AI Just What the Doctor-or Patient-Ordered?” […]
Intelligent Technology Brings Companies To A New Moment Of Truth
“Algorithms have long been used to uncover correlations but now they are closing in on more human-like abilities such as common sense and the understanding of causation.” Paul R. Daugherty and H. James Wilson, discuss in this article the future of AI and refer to it as A New Moment of Truth. GNS causal AI […]
GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases
CAMBRIDGE, Mass. – August 10, 2017– GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to large and diverse data sets to better match drugs and other health interventions to individual patients, today announced that it has entered into a license arrangement with Alexion for the rights to operate its REFS™ […]
Modern Healthcare Reports Horizon Investment in GNS, Notes Diverse Stakeholders Among GNS Investors
Another Blues plan has invested in a small Cambridge, Mass.-based company that uses big data and computer modeling to help clinicians and researchers target treatments to individuals. Read the full article here.
GNS Healthcare Study with Pfizer Reveals Discovery of Novel Clinical Risk Factors Driving Progression to Type 2 Diabetes and Prediabetes
Published by the Journal of Diabetes Science and Technology, Discoveries Result From Computer Models Created From EHR Data and Causal Machine Learning Technology CAMBRIDGE, Mass. – Feb. 29, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new intervention […]
Wall Street Journal Article Highlights Role of Consumer Data in Employee Wellness Programs
Employee wellness firms and insurers are working with companies to mine data about the prescription drugs workers use, how they shop and even whether they vote, to predict their individual health needs and recommend treatments. Read the full article here.
The Multiple Myeloma Research Foundation and GNS Healthcare Uncover Novel Drivers of Clinical Outcomes in Multiple Myeloma
Results of Big Data and Machine Learning Collaboration Featured at American Society of Hematology Annual Meeting NORWALK, Conn. and CAMBRIDGE, Mass. – Dec. 5, 2015 –The Multiple Myeloma Research Foundation (MMRF), a leader in accelerating the development of breakthrough multiple myeloma therapies, and GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning […]
Retrofit Partners with GNS Healthcare to Revolutionize Weight Loss
CHICAGO and CAMBRIDGE, Mass. – Sept. 28, 2015 –Retrofit,a leading provider of corporate weight management programs, and GNS Healthcare (GNS), a leading provider of analytics that drive personalized interventions to improve population health, today announced a partnership that will transform how Retrofit uses data to help clients lose weight. Retrofit uses a high-tech, high-touch approach to […]
GNS Healthcare And CHDI Foundation Collaborate To Identify Novel Drug Targets For Huntington’s Disease
Scientific team using state-of-the-art technology to analyze vast dataset CAMBRIDGE, Mass. and NEW YORK CITY – Nov. 12, 2014 – GNS Healthcare (GNS), a leading provider of big data analytics in health care, announced today that CHDI Foundation, Inc. (CHDI), a privately-funded, nonprofit biomedical research organization exclusively dedicated to Huntington’s disease, has committed to continuing […]